CarsonAllaria Wealth Management’s VolitionRx Ltd VNRX Stock Holding History

CarsonAllaria Wealth Management’s Portfolio VNRX Stock Details VNRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-113	Closed	-$3.15K	–	406
2023 Q2	$3.15K	Hold	113	–	–	﹤0.01%	295
2023 Q1	$4.33K	Hold	113	–	–	﹤0.01%	263
2022 Q4	$6K	Sell	113 -29	-20%	-$1.13K	0.01%	226
2022 Q3	$4K	Hold	142	–	–	﹤0.01%	250
2022 Q2	$6K	Hold	142	–	–	0.01%	221
2022 Q1	$9K	Hold	142	–	–	0.01%	206
2021 Q4	$9K	Buy	+142	New	+$9.69K	0.01%	216

Other funds holding VNRX

LIM

Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SAMC

Spectrum Asset Management (California) Newport Beach, California $315M AUM 19.93% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

CarsonAllaria Wealth Management's VNRX Position: Q3 2023 in Review

CarsonAllaria Wealth Management sold out of VolitionRx Ltd (VNRX) in Q3 2023, closing a stake of 113 shares — an estimated $3.15K sold.

CarsonAllaria Wealth Management first reported a position in VNRX in Q4 2021 and held it in 7 quarters. The position peaked at $9K in Q1 2022. 28 funds tracked by Wall St. Rank hold VNRX as of Q3 2023.

CarsonAllaria Wealth Management reported no remaining VolitionRx Ltd position as of Q3 2023 after selling out during the quarter.
CarsonAllaria Wealth Management sold 113 VolitionRx Ltd shares in Q3 2023, an estimated $3.15K.
CarsonAllaria Wealth Management first reported a position in VolitionRx Ltd in Q4 2021 and held it in 7 quarters.
CarsonAllaria Wealth Management's VolitionRx Ltd position peaked at $9K in Q1 2022.
28 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q3 2023.

Based on CarsonAllaria Wealth Management's 13F filing for Q3 2023, filed 9 Nov 2023.